Question · asked by 1 review
Group C cognitive behavioural therapy: cognitive behavioural therapy + risperidone vs placebo or supportive treatment: Behaviour: clinically important change in behaviour
- Population
- people in the prodromal stage of psychosis
- Intervention
- Group C cognitive behavioural therapy: cognitive behavioural therapy + risperidone
- Comparison
- placebo or supportive treatment
- Outcome
- Behaviour: clinically important change in behaviour
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Group C cognitive behavioural therapy: cognitive behavioural therapy + risperidone vs supportive therapy + placebo Behaviour: clinically important change in behaviour · people in the prodromal stage of psychosis Interventions for prodromal stage of psychosis (2019) · Cochrane Headline outcomes only | no estimate extracted | 0 studies · 0 participants | GRADE not reported |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.